Amols H I, Bradbury J N, Dicello J F, Helland J A, Kligerman M M, Lane T F, Paciotti M A, Roeder D L, Schillaci M E
Phys Med Biol. 1978 May;23(3):385-96. doi: 10.1088/0031-9155/23/3/002.
Irradiation of humans with negative pions requires a knowledge of the absorbed dose and radiation quality outside the primary pion beam. In conjunction with early clinical trials at LAMPF, experimental data have been obtained with microdosimetric techniques and multiwire proportional counters. Theoretical calculations have been made for the neutron contribution to the dose and are consistent with these data. Measurements were made with in 40 cm x 51 cm x 76 cm water phantom for a negative pion beam of initial momentum of 170 MeV/c, deltap = +/- 3MeV/c. The absorbed dose outside the treatment volume is the result of: (1) neutrons and photons from the pion interactions,(2) treatment room background and (3) peripheral muons, electrons and pions in the primary beam. The first two components are nearly isotropic and are congruent to 0.02% of the peak dose at a distance of 24 cm from the treatment volume; the third component is anisotropic and varies from 0.01 to 0.1% of the peak dose. Collimation of the bean increases the dose outside the treatment volume typically by 50%.
用负π介子对人体进行照射需要了解初级π介子束外的吸收剂量和辐射品质。结合在劳仑斯伯克利国家实验室(LAMPF)进行的早期临床试验,利用微剂量学技术和多丝正比计数器获得了实验数据。已经对中子对剂量的贡献进行了理论计算,并且与这些数据一致。在一个40厘米×51厘米×76厘米的水模体中,对初始动量为170兆电子伏特/光速、动量分散为±3兆电子伏特/光速的负π介子束进行了测量。治疗体积外的吸收剂量是以下因素的结果:(1)来自π介子相互作用的中子和光子,(2)治疗室本底,以及(3)初级束中的外围μ子、电子和π介子。前两个成分几乎是各向同性的,在距离治疗体积24厘米处相当于峰值剂量的0.02%;第三个成分是各向异性的,在峰值剂量的0.01%至0.1%之间变化。束流的准直通常会使治疗体积外的剂量增加50%。